Onconetix, Inc. Proceeds from Sale of Other Investments
Onconetix, Inc. (ONCO) reported Proceeds from Sale of Other Investments of $2.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherInvestments · last filed 2024-04-11
- Onconetix, Inc. proceeds from sale of other investments for the quarter ending 2023-12-31 was $0.00.
- Onconetix, Inc. proceeds from sale of other investments for fiscal 2023 was $2.30M.
| Period end | Proceeds from Sale of Other Investments 3 month | Proceeds from Sale of Other Investments 9 month | Proceeds from Sale of Other Investments 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $2.30M 10-K · filed 2024-04-11 | |
| 2023-09-30 | $2.30M 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |